HLA-DQA1 and cancer: Consistently, in previous studies, a high expression of TIMP1 (54, 55), VCAN, KRT8 (56–58), and FABP5 (59) and a low expression of SFTPB (60, 61), WFDC2 (62, 63), and HLA-DQA1 (64, 65) were associated with poor prognosis in multiple cancer types.